▶ 調査レポート

世界の薬物検査用動物モデル市場インサイト・予測(~2027年)

• 英文タイトル:Global Animal Model for Drug Testing Market Insights and Forecast to 2027

QYResearchが調査・発行した産業分析レポートです。世界の薬物検査用動物モデル市場インサイト・予測(~2027年) / Global Animal Model for Drug Testing Market Insights and Forecast to 2027 / QY2112A04975資料のイメージです。• レポートコード:QY2112A04975
• 出版社/出版日:QYResearch / 2021年11月
• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥651,700 (USD4,900)▷ お問い合わせ
  Multi User¥977,550 (USD7,350)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は薬物検査用動物モデルの世界市場の現状について調査・分析し、2027年までの市場を予測しました。薬物検査用動物モデルの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模(ラット、マウス、その他)、用途別市場規模(学術・研究機関、製薬・バイオテクノロジー企業)、主要地域別市場規模(北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ)、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・薬物検査用動物モデルの世界市場概要
・メーカー別の競争状況、市場シェア
・薬物検査用動物モデルの種類別市場規模:ラット、マウス、その他
・薬物検査用動物モデルの用途別市場規模:学術・研究機関、製薬・バイオテクノロジー企業
・北米の薬物検査用動物モデル市場規模2016-2027:種類別、用途別、国別(アメリカ、カナダ)
・ヨーロッパの薬物検査用動物モデル市場規模2016-2027:種類別、用途別、国別(ドイツ、フランス、イギリス)
・アジアの薬物検査用動物モデル市場規模2016-2027:種類別、用途別、国別(日本、中国、インド、韓国)
・中南米の薬物検査用動物モデル市場規模2016-2027:種類別、用途別、国別(メキシコ、ブラジル)
・中東・アフリカの薬物検査用動物モデル市場規模2016-2027:種類別、用途別、国別(トルコ、サウジアラビア)
・企業情報:Charles River Laboratories、Envigo、Taconic Biosciences、Jackson Laboratory、Crown Biosciences、Shanghai SLAC、Shangghai Modelorg、GenOway、Syngene International、Psychogenics、Pharmaron、Pharmalegacy、Vitalstar Biotechnology
・薬物検査用動物モデルのバリューチェーン・販売チャネル分析
・薬物検査用動物モデルの世界市場動向

Market Analysis and Insights: Global Animal Model for Drug Testing Market
The global Animal Model for Drug Testing market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Animal Model for Drug Testing Scope and Segment
Animal Model for Drug Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Animal Model for Drug Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Rats
Mice
Others

Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies

By Company
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Animal Model for Drug Testing Product Introduction
1.2 Market by Type
1.2.1 Global Animal Model for Drug Testing Market Size Growth Rate by Type
1.2.2 Rats
1.2.3 Mice
1.2.4 Others
1.3 Market by Application
1.3.1 Global Animal Model for Drug Testing Market Size Growth Rate by Application
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Animal Model for Drug Testing Sales Estimates and Forecasts 2016-2027
2.2 Global Animal Model for Drug Testing Revenue Estimates and Forecasts 2016-2027
2.3 Global Animal Model for Drug Testing Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Animal Model for Drug Testing Regions by Sales
2.4.1 Global Top Animal Model for Drug Testing Regions by Sales (2016-2021)
2.4.2 Global Top Animal Model for Drug Testing Regions by Sales (2022-2027)
2.5 Global Top Animal Model for Drug Testing Regions by Revenue
2.5.1 Global Top Animal Model for Drug Testing Regions by Revenue (2016-2021)
2.5.2 Global Top Animal Model for Drug Testing Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Animal Model for Drug Testing Sales by Manufacturers
3.1.1 Global Top Animal Model for Drug Testing Manufacturers by Sales (2016-2021)
3.1.2 Global Top Animal Model for Drug Testing Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Animal Model for Drug Testing Sales in 2020
3.2 Global Animal Model for Drug Testing Revenue by Manufacturers
3.2.1 Global Top Animal Model for Drug Testing Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Animal Model for Drug Testing Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Animal Model for Drug Testing Revenue in 2020
3.3 Global Animal Model for Drug Testing Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Animal Model for Drug Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Animal Model for Drug Testing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Animal Model for Drug Testing Sales by Type
4.1.1 Global Animal Model for Drug Testing Historical Sales by Type (2016-2021)
4.1.2 Global Animal Model for Drug Testing Forecasted Sales by Type (2022-2027)
4.1.3 Global Animal Model for Drug Testing Sales Market Share by Type (2016-2027)
4.2 Global Animal Model for Drug Testing Revenue by Type
4.2.1 Global Animal Model for Drug Testing Historical Revenue by Type (2016-2021)
4.2.2 Global Animal Model for Drug Testing Forecasted Revenue by Type (2022-2027)
4.2.3 Global Animal Model for Drug Testing Revenue Market Share by Type (2016-2027)
4.3 Global Animal Model for Drug Testing Price by Type
4.3.1 Global Animal Model for Drug Testing Price by Type (2016-2021)
4.3.2 Global Animal Model for Drug Testing Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Animal Model for Drug Testing Sales by Application
5.1.1 Global Animal Model for Drug Testing Historical Sales by Application (2016-2021)
5.1.2 Global Animal Model for Drug Testing Forecasted Sales by Application (2022-2027)
5.1.3 Global Animal Model for Drug Testing Sales Market Share by Application (2016-2027)
5.2 Global Animal Model for Drug Testing Revenue by Application
5.2.1 Global Animal Model for Drug Testing Historical Revenue by Application (2016-2021)
5.2.2 Global Animal Model for Drug Testing Forecasted Revenue by Application (2022-2027)
5.2.3 Global Animal Model for Drug Testing Revenue Market Share by Application (2016-2027)
5.3 Global Animal Model for Drug Testing Price by Application
5.3.1 Global Animal Model for Drug Testing Price by Application (2016-2021)
5.3.2 Global Animal Model for Drug Testing Price Forecast by Application (2022-2027)

6 North America
6.1 North America Animal Model for Drug Testing Market Size by Type
6.1.1 North America Animal Model for Drug Testing Sales by Type (2016-2027)
6.1.2 North America Animal Model for Drug Testing Revenue by Type (2016-2027)
6.2 North America Animal Model for Drug Testing Market Size by Application
6.2.1 North America Animal Model for Drug Testing Sales by Application (2016-2027)
6.2.2 North America Animal Model for Drug Testing Revenue by Application (2016-2027)
6.3 North America Animal Model for Drug Testing Market Size by Country
6.3.1 North America Animal Model for Drug Testing Sales by Country (2016-2027)
6.3.2 North America Animal Model for Drug Testing Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Animal Model for Drug Testing Market Size by Type
7.1.1 Europe Animal Model for Drug Testing Sales by Type (2016-2027)
7.1.2 Europe Animal Model for Drug Testing Revenue by Type (2016-2027)
7.2 Europe Animal Model for Drug Testing Market Size by Application
7.2.1 Europe Animal Model for Drug Testing Sales by Application (2016-2027)
7.2.2 Europe Animal Model for Drug Testing Revenue by Application (2016-2027)
7.3 Europe Animal Model for Drug Testing Market Size by Country
7.3.1 Europe Animal Model for Drug Testing Sales by Country (2016-2027)
7.3.2 Europe Animal Model for Drug Testing Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Animal Model for Drug Testing Market Size by Type
8.1.1 Asia Pacific Animal Model for Drug Testing Sales by Type (2016-2027)
8.1.2 Asia Pacific Animal Model for Drug Testing Revenue by Type (2016-2027)
8.2 Asia Pacific Animal Model for Drug Testing Market Size by Application
8.2.1 Asia Pacific Animal Model for Drug Testing Sales by Application (2016-2027)
8.2.2 Asia Pacific Animal Model for Drug Testing Revenue by Application (2016-2027)
8.3 Asia Pacific Animal Model for Drug Testing Market Size by Region
8.3.1 Asia Pacific Animal Model for Drug Testing Sales by Region (2016-2027)
8.3.2 Asia Pacific Animal Model for Drug Testing Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Animal Model for Drug Testing Market Size by Type
9.1.1 Latin America Animal Model for Drug Testing Sales by Type (2016-2027)
9.1.2 Latin America Animal Model for Drug Testing Revenue by Type (2016-2027)
9.2 Latin America Animal Model for Drug Testing Market Size by Application
9.2.1 Latin America Animal Model for Drug Testing Sales by Application (2016-2027)
9.2.2 Latin America Animal Model for Drug Testing Revenue by Application (2016-2027)
9.3 Latin America Animal Model for Drug Testing Market Size by Country
9.3.1 Latin America Animal Model for Drug Testing Sales by Country (2016-2027)
9.3.2 Latin America Animal Model for Drug Testing Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Animal Model for Drug Testing Market Size by Type
10.1.1 Middle East and Africa Animal Model for Drug Testing Sales by Type (2016-2027)
10.1.2 Middle East and Africa Animal Model for Drug Testing Revenue by Type (2016-2027)
10.2 Middle East and Africa Animal Model for Drug Testing Market Size by Application
10.2.1 Middle East and Africa Animal Model for Drug Testing Sales by Application (2016-2027)
10.2.2 Middle East and Africa Animal Model for Drug Testing Revenue by Application (2016-2027)
10.3 Middle East and Africa Animal Model for Drug Testing Market Size by Country
10.3.1 Middle East and Africa Animal Model for Drug Testing Sales by Country (2016-2027)
10.3.2 Middle East and Africa Animal Model for Drug Testing Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Corporation Information
11.1.2 Charles River Laboratories Overview
11.1.3 Charles River Laboratories Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Charles River Laboratories Animal Model for Drug Testing Product Description
11.1.5 Charles River Laboratories Recent Developments
11.2 Envigo
11.2.1 Envigo Corporation Information
11.2.2 Envigo Overview
11.2.3 Envigo Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Envigo Animal Model for Drug Testing Product Description
11.2.5 Envigo Recent Developments
11.3 Taconic Biosciences
11.3.1 Taconic Biosciences Corporation Information
11.3.2 Taconic Biosciences Overview
11.3.3 Taconic Biosciences Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Taconic Biosciences Animal Model for Drug Testing Product Description
11.3.5 Taconic Biosciences Recent Developments
11.4 Jackson Laboratory
11.4.1 Jackson Laboratory Corporation Information
11.4.2 Jackson Laboratory Overview
11.4.3 Jackson Laboratory Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Jackson Laboratory Animal Model for Drug Testing Product Description
11.4.5 Jackson Laboratory Recent Developments
11.5 Crown Biosciences
11.5.1 Crown Biosciences Corporation Information
11.5.2 Crown Biosciences Overview
11.5.3 Crown Biosciences Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Crown Biosciences Animal Model for Drug Testing Product Description
11.5.5 Crown Biosciences Recent Developments
11.6 Shanghai SLAC
11.6.1 Shanghai SLAC Corporation Information
11.6.2 Shanghai SLAC Overview
11.6.3 Shanghai SLAC Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Shanghai SLAC Animal Model for Drug Testing Product Description
11.6.5 Shanghai SLAC Recent Developments
11.7 Shangghai Modelorg
11.7.1 Shangghai Modelorg Corporation Information
11.7.2 Shangghai Modelorg Overview
11.7.3 Shangghai Modelorg Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Shangghai Modelorg Animal Model for Drug Testing Product Description
11.7.5 Shangghai Modelorg Recent Developments
11.8 GenOway
11.8.1 GenOway Corporation Information
11.8.2 GenOway Overview
11.8.3 GenOway Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 GenOway Animal Model for Drug Testing Product Description
11.8.5 GenOway Recent Developments
11.9 Syngene International
11.9.1 Syngene International Corporation Information
11.9.2 Syngene International Overview
11.9.3 Syngene International Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Syngene International Animal Model for Drug Testing Product Description
11.9.5 Syngene International Recent Developments
11.10 Psychogenics
11.10.1 Psychogenics Corporation Information
11.10.2 Psychogenics Overview
11.10.3 Psychogenics Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Psychogenics Animal Model for Drug Testing Product Description
11.10.5 Psychogenics Recent Developments
11.11 Pharmaron
11.11.1 Pharmaron Corporation Information
11.11.2 Pharmaron Overview
11.11.3 Pharmaron Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Pharmaron Animal Model for Drug Testing Product Description
11.11.5 Pharmaron Recent Developments
11.12 Pharmalegacy
11.12.1 Pharmalegacy Corporation Information
11.12.2 Pharmalegacy Overview
11.12.3 Pharmalegacy Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Pharmalegacy Animal Model for Drug Testing Product Description
11.12.5 Pharmalegacy Recent Developments
11.13 Vitalstar Biotechnology
11.13.1 Vitalstar Biotechnology Corporation Information
11.13.2 Vitalstar Biotechnology Overview
11.13.3 Vitalstar Biotechnology Animal Model for Drug Testing Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Vitalstar Biotechnology Animal Model for Drug Testing Product Description
11.13.5 Vitalstar Biotechnology Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Animal Model for Drug Testing Value Chain Analysis
12.2 Animal Model for Drug Testing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Animal Model for Drug Testing Production Mode & Process
12.4 Animal Model for Drug Testing Sales and Marketing
12.4.1 Animal Model for Drug Testing Sales Channels
12.4.2 Animal Model for Drug Testing Distributors
12.5 Animal Model for Drug Testing Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Animal Model for Drug Testing Industry Trends
13.2 Animal Model for Drug Testing Market Drivers
13.3 Animal Model for Drug Testing Market Challenges
13.4 Animal Model for Drug Testing Market Restraints

14 Key Findings in The Global Animal Model for Drug Testing Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer